SIAP
MLNT

Sterling Investment Advisors (Pennsylvania)’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-19
Closed – – 465
2019
Q4 		$0 Hold
19
– – ﹤0.01% 460
2019
Q3 		$0 Hold
19
– – ﹤0.01% 459
2019
Q2 		$0 Hold
19
– – ﹤0.01% 460
2019
Q1 		$0 Hold
19
– – ﹤0.01% 442
2018
Q4 		$0 Hold
19
– – ﹤0.01% 446
2018
Q3 		$0 Hold
19
– – ﹤0.01% 444
2018
Q2 		$0 Hold
19
– – ﹤0.01% 414
2018
Q1 		$1K Hold
19
– – ﹤0.01% 368
2017
Q4 		$2K Buy
+19
New +$1.41K ﹤0.01% 337

Sterling Investment Advisors (Pennsylvania)'s MLNT Position: Q1 2020 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 19 shares.

Sterling Investment Advisors (Pennsylvania) first reported a position in MLNT in Q4 2017 and held it in 9 quarters. The position peaked at $2K in Q4 2017. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 19 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Melinta Therapeutics, Inc. Common Stock in Q4 2017 and held it in 9 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Melinta Therapeutics, Inc. Common Stock position peaked at $2K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q1 2020, filed 30 Apr 2020.